| scholarly article | Q13442814 |
| P50 | author | Michael J. Keating | Q66429598 |
| P2093 | author name string | Yan Zhou | |
| Peng Huang | |||
| Li Feng | |||
| Zhao Chen | |||
| Seiji Kondo | |||
| Yunfei Zhou | |||
| Marcia Ogasawara | |||
| Takashi Shingu | |||
| P2860 | cites work | Development and validation of an integrated computational model of cerebral blood flow and oxygenation. | Q48560011 |
| Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. | Q50466801 | ||
| FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma. | Q55482724 | ||
| The role of hypoxia in the maintenance of hematopoietic stem cells | Q72233363 | ||
| Brain tumors | Q73377286 | ||
| STUDIES ON SUCCINATE-TETRAZOLIUM REDUCTASE SYSTEMS. III. POINTS OF COUPLING OF FOUR DIFFERENT TETRAZOLIUM SALTS | Q76640750 | ||
| Cancer stem cells | Q80312237 | ||
| Prospective identification of tumorigenic breast cancer cells | Q24683474 | ||
| A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas | Q24811594 | ||
| Glioma stem cells promote radioresistance by preferential activation of the DNA damage response | Q27860541 | ||
| On the Origin of Cancer Cells | Q27861025 | ||
| Identification of a cancer stem cell in human brain tumors | Q28131688 | ||
| A cell initiating human acute myeloid leukaemia after transplantation into SCID mice | Q28131777 | ||
| Mitochondrial tumour suppressors: a genetic and biochemical update | Q28285094 | ||
| Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase | Q28302589 | ||
| A perivascular niche for brain tumor stem cells | Q29614276 | ||
| The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype | Q29615563 | ||
| Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines | Q29615823 | ||
| Applying the principles of stem-cell biology to cancer | Q29622827 | ||
| Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia | Q33279493 | ||
| Low O2 tensions and the prevention of differentiation of hES cells | Q33932268 | ||
| Stem cells find their niche | Q34100153 | ||
| Isolation, Characterization, and use of Stem Cells from the CNS | Q34299470 | ||
| Preferential induction of apoptosis for primary human leukemic stem cells | Q34415832 | ||
| HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. | Q34471121 | ||
| Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. | Q34525433 | ||
| Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. | Q34554861 | ||
| Hypoxia-inducible factors, stem cells, and cancer | Q34625782 | ||
| Primary Bioassay of Human Tumor Stem Cells | Q34661809 | ||
| Cancer stem cells and oncology therapeutics | Q36667691 | ||
| Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target | Q37439503 | ||
| Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. | Q40060668 | ||
| Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death | Q40082305 | ||
| HIF-dependent antitumorigenic effect of antioxidants in vivo | Q40085629 | ||
| Hypoxia requires notch signaling to maintain the undifferentiated cell state | Q40356897 | ||
| Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model | Q40402274 | ||
| The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells | Q43143482 | ||
| Mitochondria: determinants of stem cell fate? | Q45948098 | ||
| Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells. | Q46020210 | ||
| A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes | Q48413417 | ||
| P433 | issue | 37 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| glioblastoma | Q282142 | ||
| P304 | page(s) | 32843-32853 | |
| P577 | publication date | 2011-07-27 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis | |
| P478 | volume | 286 |
| Q64912959 | Adaptive Changes of Glioblastoma Cells Following Exposure to Hypoxic (1% Oxygen) Tumour Microenvironment. |
| Q42317561 | Adenosine A3 receptor elicits chemoresistance mediated by multiple resistance-associated protein-1 in human glioblastoma stem-like cells |
| Q28545071 | Analysis of the cytotoxicity of carbon-based nanoparticles, diamond and graphite, in human glioblastoma and hepatoma cell lines |
| Q46454434 | Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1α expression in patients with glioma |
| Q90733830 | Bioactive lipids in cancer stem cells |
| Q34007740 | Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment. |
| Q55296899 | Cancer Stem Cell Metabolism and Potential Therapeutic Targets. |
| Q36014432 | Cancer Stem Cells in Small Cell Lung Cancer Cell Line H446: Higher Dependency on Oxidative Phosphorylation and Mitochondrial Substrate-Level Phosphorylation than Non-Stem Cancer Cells |
| Q26746123 | Cancer stem cell metabolism |
| Q88682384 | Cancer stem cell metabolism: target for cancer therapy |
| Q38782506 | Cancer stem cell molecular reprogramming of the Warburg effect in glioblastomas: a new target gleaned from an old concept |
| Q55254924 | Cancer stem cells (CSCs): metabolic strategies for their identification and eradication. |
| Q38728744 | Cancer stem cells, metabolism, and therapeutic significance |
| Q55396904 | Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism. |
| Q40283731 | Colony, hanging drop, and methylcellulose three dimensional hypoxic growth optimization of renal cell carcinoma cell lines |
| Q39028792 | Control of glioma cell death and differentiation by PKM2-Oct4 interaction |
| Q89579571 | Crosstalk between autophagy and metabolic regulation of cancer stem cells |
| Q47948290 | Drug repurposing for the treatment of glioblastoma multiforme. |
| Q35742493 | Elevated NIBP/TRAPPC9 mediates tumorigenesis of cancer cells through NFκB signaling |
| Q52726871 | Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States. |
| Q91689957 | Endocytosis-mediated mitochondrial transplantation: Transferring normal human astrocytic mitochondria into glioma cells rescues aerobic respiration and enhances radiosensitivity |
| Q33718203 | Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells. |
| Q92670414 | Evaluating antibacterial and anticancer activity of crude extracts of bacterial endophytes from Crinum macowanii Baker bulbs |
| Q37740767 | Exploring the differences in metabolic behavior of astrocyte and glioblastoma: a flux balance analysis approach. |
| Q36351072 | Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors. |
| Q48610619 | Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia |
| Q50134165 | Hexokinase 2 and nuclear factor erythroid 2-related factor 2 transcriptionally coactivate xanthine oxidoreductase expression in stressed glioma cells. |
| Q33727858 | High grade glioblastoma is associated with aberrant expression of ZFP57, a protein involved in gene imprinting, and of CPT1A and CPT1C that regulate fatty acid metabolism |
| Q55457019 | Hyperbaric oxygen inhibits production of CD3+ T cells in the thymus and facilitates malignant glioma cell growth. |
| Q35803805 | Hyperbaric oxygen promotes malignant glioma cell growth and inhibits cell apoptosis |
| Q35621293 | Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability |
| Q97419063 | Hypoxia, metabolism, and the circadian clock: new links to overcome radiation resistance in high-grade gliomas |
| Q97419840 | Identification of Chemoresistance-Associated Key Genes and Pathways in High-Grade Serous Ovarian Cancer by Bioinformatics Analyses |
| Q36978100 | Identification of novel hypoxia response genes in human glioma cell line a172 |
| Q36480199 | In Vivo Loss of Function Screening Reveals Carbonic Anhydrase IX as a Key Modulator of Tumor Initiating Potential in Primary Pancreatic Tumors |
| Q39090175 | Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner |
| Q35038005 | Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells |
| Q57788762 | Intra-tumoral treatment with oxygen-ozone in glioblastoma: A systematic literature search and results of a case series |
| Q36192530 | Lactate dehydrogenase-A inhibition induces human glioblastoma multiforme stem cell differentiation and death |
| Q38737023 | Laminin-adherent versus suspension-non-adherent cell culture conditions for the isolation of cancer stem cells in the DAOY medulloblastoma cell line. |
| Q38700019 | Loss of fructose-1,6-bisphosphatase induces glycolysis and promotes apoptosis resistance of cancer stem-like cells: an important role in hexavalent chromium-induced carcinogenesis |
| Q89458804 | MCT4 regulates de novo pyrimidine biosynthesis in GBM in a lactate-independent manner |
| Q92875529 | Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance |
| Q97525205 | Metabolic Adaptations in Cancer Stem Cells |
| Q36882685 | Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program |
| Q39297355 | Metabolic Reprogramming in Glioma. |
| Q36163766 | Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanism |
| Q52731934 | Metabolic features of cancer stem cells: the emerging role of lipid metabolism. |
| Q50089305 | Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model. |
| Q101038959 | Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma |
| Q35008587 | Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway. |
| Q48179985 | Metabolic regulation of glioma stem-like cells in the tumor micro-environment |
| Q93068246 | Metabolic signatures of cancer cells and stem cells |
| Q64906270 | Metabolic traits of cancer stem cells. |
| Q64061518 | Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells |
| Q55457086 | Microvascular fractal dimension predicts prognosis and response to chemotherapy in glioblastoma: an automatic image analysis study. |
| Q43923356 | Mitochondria malfunctions as mediators of stem-cells’ related carcinogenesis: A hypothesis that supports the highly conserved profile of carcinogenesis |
| Q37477802 | Mitochondrial DNA mutations and breast tumorigenesis |
| Q60930189 | Mitochondrial Substrate-Level Phosphorylation as Energy Source for Glioblastoma: Review and Hypothesis |
| Q98200506 | Mitochondrial TXNRD3 confers drug resistance via redox-mediated mechanism and is a potential therapeutic target in vivo |
| Q34378306 | Neural stem/progenitor cells display a low requirement for oxidative metabolism independent of hypoxia inducible factor-1alpha expression |
| Q47103210 | New therapies for advanced, recurrent, and metastatic endometrial cancers. |
| Q98166036 | Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools |
| Q93369543 | Novel therapies hijack the blood-brain barrier to eradicate glioblastoma cancer stem cells |
| Q28538384 | Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism |
| Q91763529 | Ovarian cancer stem cells and targeted therapy |
| Q34658326 | Ovarian tumor-initiating cells display a flexible metabolism |
| Q35169487 | PERK silence inhibits glioma cell growth under low glucose stress by blockage of p-AKT and subsequent HK2's mitochondria translocation. |
| Q42293431 | Redox-Related Epigenetic Mechanisms in Glioblastoma: Nuclear Factor (Erythroid-Derived 2)-Like 2, Cobalamin, and Dopamine Receptor Subtype 4 |
| Q48133992 | Regulation of Cancer Stem Cell Metabolism by Secreted Frizzled-Related Protein 4 (sFRP4). |
| Q32181276 | Regulation of stem-like cancer cells by glutamine through β-catenin pathway mediated by redox signaling |
| Q32186656 | Requirement of ABC transporter inhibition and Hoechst 33342 dye deprivation for the assessment of side population-defined C6 glioma stem cell metabolism using fluorescent probes |
| Q47117433 | Riluzole: a potential therapeutic intervention in human brain tumor stem-like cells |
| Q89700549 | Roles of PFKFB3 in cancer |
| Q51016658 | SIRT6 regulated nucleosomal occupancy affects Hexokinase 2 expression. |
| Q21285139 | Salinomycin as a Drug for Targeting Human Cancer Stem Cells |
| Q27314916 | Short-Term Differentiation of Glioblastoma Stem Cells Induces Hypoxia Tolerance |
| Q35802983 | Targeted therapy against cancer stem cells |
| Q38889490 | Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways |
| Q92524783 | Targeting reduced mitochondrial DNA quantity as a therapeutic approach in pediatric high-grade gliomas |
| Q39205930 | Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors |
| Q35176105 | Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells |
| Q61447495 | The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma |
| Q47834398 | The Pro-tumorigenic Effects of Metabolic Alterations in Glioblastoma Including Brain Tumor Initiating Cells |
| Q90175728 | The Quiescent Metabolic Phenotype of Glioma Stem Cells |
| Q48532756 | The angiogenic switch leads to a metabolic shift in human glioblastoma |
| Q37551852 | The identification of mitochondrial DNA variants in glioblastoma multiforme |
| Q38580323 | The metabolic landscape of cancer stem cells |
| Q26766079 | The sweet trap in tumors: aerobic glycolysis and potential targets for therapy |
| Q36103152 | Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy Balance. |
| Q28080881 | Type 3 deiodinase: role in cancer growth, stemness, and metabolism |
| Q41071162 | Upregulation of mitochondrial NAD+ levels impairs the clonogenicity of SSEA1+ glioblastoma tumor-initiating cells |
| Q58700437 | VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells |
| Q39200427 | miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells |
Search more.